UAE announces new rules to end medicine monopolies with multiple agents per drug
The Emirates Drug Establishment has announced measures to end the monopoly of medical products in the UAE.The Establishment announced that the new mechanism requires pharmaceutical companies to appoint more than one agent for each medical product.This step is the first of its kind in the healthcare sector to strengthen drug security.Stay up to date with the latest news. Follow KT on WhatsApp Channels.The new mechanism aims to end monopolistic practices and ensure the continuous availability of medical products.The mechanism helps reduce the risks of supply disruptions during emergencies and crises.It supports pharmaceutical investment and enhances the UAE's global competitiveness.Medicine prices in UAE under review as officials admit cost gapUAE issues new law on veterinary products, bans trade of fake, unsafe animal drugs
The Emirates Drug Establishment has announced measures to end the monopoly of medical products in the UAE.
The Establishment announced that the new mechanism requires pharmaceutical companies to appoint more than one agent for each medical product.
This step is the first of its kind in the healthcare sector to strengthen drug security.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
The new mechanism aims to end monopolistic practices and ensure the continuous availability of medical products.
The mechanism helps reduce the risks of supply disruptions during emergencies and crises.
It supports pharmaceutical investment and enhances the UAE's global competitiveness.
What's Your Reaction?
